0
Skip to Content
BioscienceLA
About Us
Our Team
Sponsors
Library
Media
News
BioscienceLA Week
About
Host an Event
Donate
BioscienceLA
About Us
Our Team
Sponsors
Library
Media
News
BioscienceLA Week
About
Host an Event
Donate
Folder: About
Back
About Us
Our Team
Sponsors
Library
Media
News
Folder: Programs
Back
BioscienceLA Week
Folder: Culver City Facility
Back
About
Host an Event
Donate
FDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Ecosystem News Sree Batchu 5/28/21 Ecosystem News Sree Batchu 5/28/21

FDA Approves LUMAKRAS™ (Sotorasib), The First And Only Targeted Treatment For Patients With KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

Read More
Scopus BioPharma Announces IND Submission to FDA for Lead Drug Candidate
Industry News Sree Batchu 5/10/21 Industry News Sree Batchu 5/10/21

Scopus BioPharma Announces IND Submission to FDA for Lead Drug Candidate

Read More
A Liquid 'Shield' Used on Ebola Now Has FDA Clearance to Make Handling COVID Tests Safer for Lab Workers
Industry News Sree Batchu 3/11/21 Industry News Sree Batchu 3/11/21

A Liquid 'Shield' Used on Ebola Now Has FDA Clearance to Make Handling COVID Tests Safer for Lab Workers

Read More
FDA Approves Gilead/Kite's Yescarta as First CAR-T for Follicular Lymphoma
Industry News Sree Batchu 3/8/21 Industry News Sree Batchu 3/8/21

FDA Approves Gilead/Kite's Yescarta as First CAR-T for Follicular Lymphoma

Read More
U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma
Ecosystem News Guest User 7/24/20 Ecosystem News Guest User 7/24/20

U.S. FDA Approves Kite’s Tecartus™, the First and Only CAR T Treatment for Relapsed or Refractory Mantle Cell Lymphoma

Read More
 
BioscienceLA

Subscribe

Receive our bi-weekly newsletter and occasional special alerts.

Thank you! Have something of interest to the ecosystem? Email info@biosciencela.org with your ideas.

 

ABOUT 

OUR TEAM

CONTACT

LIBRARY

MEDIA

NEWS

Bioscience Los Angeles County, Inc. (“BioscienceLA”) is an independent 501(c)(3) not-for-profit organization formed by Los Angeles County in 2018 with backing from Amgen, PhRMA, Richard Lundquist, Richard Merkin, City of Hope, and Cedars-Sinai, among others. It was formed to create, enable, and promote an enviable, thriving, and vibrant life sciences ecosystem in Greater Los Angeles to produce economic and societal benefits in the region.

 

© 2026 Bioscience Los Angeles County Inc. All Rights Reserved.  Terms of Use  |  Privacy Policy